The Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, United States of America.
Engineering Science and Mechanics Department, Penn State University, University Park, PA 16802, United States of America.
Biofabrication. 2023 Nov 20;16(1):012003. doi: 10.1088/1758-5090/ad0b3f.
Three-dimensional (3D) bioprinting offers promising solutions to the complex challenge of vascularization in biofabrication, thereby enhancing the prospects for clinical translation of engineered tissues and organs. While existing reviews have touched upon 3D bioprinting in vascularized tissue contexts, the current review offers a more holistic perspective, encompassing recent technical advancements and spanning the entire multistage bioprinting process, with a particular emphasis on vascularization. The synergy between 3D bioprinting and vascularization strategies is crucial, as 3D bioprinting can enable the creation of personalized, tissue-specific vascular network while the vascularization enhances tissue viability and function. The review starts by providing a comprehensive overview of the entire bioprinting process, spanning from pre-bioprinting stages to post-printing processing, including perfusion and maturation. Next, recent advancements in vascularization strategies that can be seamlessly integrated with bioprinting are discussed. Further, tissue-specific examples illustrating how these vascularization approaches are customized for diverse anatomical tissues towards enhancing clinical relevance are discussed. Finally, the underexplored intraoperative bioprinting (IOB) was highlighted, which enables the direct reconstruction of tissues within defect sites, stressing on the possible synergy shaped by combining IOB with vascularization strategies for improved regeneration.
三维(3D)生物打印为生物制造中的血管化这一复杂挑战提供了有前景的解决方案,从而提高了工程组织和器官临床转化的前景。虽然现有的综述已经涉及到血管化组织背景下的 3D 生物打印,但本综述提供了更全面的视角,涵盖了最近的技术进展,并跨越了整个多阶段生物打印过程,特别强调了血管化。3D 生物打印和血管化策略之间的协同作用至关重要,因为 3D 生物打印可以实现个性化、组织特异性血管网络的创建,而血管化则可以提高组织的活力和功能。本综述首先全面概述了整个生物打印过程,从预打印阶段到打印后处理,包括灌注和成熟阶段。接下来,讨论了可以与生物打印无缝集成的血管化策略的最新进展。此外,还讨论了特定于组织的示例,说明这些血管化方法如何针对不同的解剖组织进行定制,以提高临床相关性。最后,强调了术中生物打印(IOB)的重要性,它可以在缺陷部位直接重建组织,并强调通过将 IOB 与血管化策略相结合以改善再生来实现可能的协同作用。